Literature DB >> 7528994

Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing.

K Ytrehus1, Y Liu, A Tsuchida, T Miura, G S Liu, X M Yang, D Herbert, M V Cohen, J M Downey.   

Abstract

Rabbits and rats are becoming popular models for in vitro as well as in situ studies of myocardial infarction. In the present analysis we evaluated the results of several of our completed investigations and tested whether blood-free perfusate, anesthesia, or risk zone size affects infarction in these species. In addition, the influence of the method used for determining infarct size (histology or histochemistry) was examined in rabbits. All hearts experienced 30 min of regional ischemia followed by either 2-3 h of reperfusion in animals in which infarct size was assessed by staining with triphenyltetrazolium chloride or 72 h in those in which histological methods were used to measure infarct size. Eighteen rabbit and seven rat hearts perfused with Krebs buffer, seventeen open-chest rabbits, eight rats anesthetized with pentobarbital, and ten conscious rabbits were studied. Risk zone size measured with fluorescent particles was plotted against infarct size. Infarct size was linearly correlated with risk zone size and did not differ among models for each species. In rat hearts the regression line passed through the origin so that zero infarction occurred with zero risk zone size. However, in the rabbit heart there was no apparent infarction for risk zone sizes < 0.3 cm3. Although the relationship between risk zone and infarction was found to be remarkably independent of the model chosen, the nonzero intercept for the rabbit heart can be an important, previously unrecognized source of experimental variability when infarct size is expressed as a percentage of the risk zone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528994     DOI: 10.1152/ajpheart.1994.267.6.H2383

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  36 in total

1.  MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation model.

Authors:  Robert F Menger; Whitney L Stutts; Dhanalakshmi S Anbukumar; John A Bowden; David A Ford; Richard A Yost
Journal:  Anal Chem       Date:  2011-12-22       Impact factor: 6.986

2.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

3.  Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective.

Authors:  Scott D Williams; Roberta A Gottlieb
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

4.  Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison.

Authors:  Satwat Hashmi; Suhail Al-Salam
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardium.

Authors:  Adrienn Kis; Derek M Yellon; Gary F Baxter
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  Preconditioning by subinotropic doses of ouabain in the Langendorff perfused rabbit heart.

Authors:  Eric E Morgan; Zhichuan Li; Cory Stebal; Aude Belliard; Glen Tennyson; Bijan Salari; Keith D Garlid; Sandrine V Pierre
Journal:  J Cardiovasc Pharmacol       Date:  2010-03       Impact factor: 3.105

7.  [Ischemic preconditioning in the aged heart--myocardial protective effect as compared with the mature heart].

Authors:  M Uematsu; M Okada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-09

8.  [Does adenosine administration during the early reperfusion period affect ischemic preconditioning?].

Authors:  M Uematsu; M Okada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-09

9.  Reduction of infarct size by the therapeutic protein TAT-Ndi1 in vivo.

Authors:  Robert M Mentzer; Joseph Wider; Cynthia N Perry; Roberta A Gottlieb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-12-23       Impact factor: 2.457

Review 10.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.